Effects of blood glucose changes and physostigmine on anesthetic requirements of halothane in rats

Anesthesiology

Volumn 87, Issue 2, 1997, Pages 354-360

  Ishizawa, Yumiko ^a   Ohta, Shuichiro ^b   Shimonaka, Hiroyuki ^b   Dohi, Shuji ^b  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

Anesthetics, volatile; Halothane; Hyperglycemia; Hypoglycemia; Physostigmine; Potency: anesthetic; minimum alveolar concentration

Indexed keywords

ACETYLCHOLINE; GLUCOSE; HALOTHANE; INSULIN; PHYSOSTIGMINE;

ACETYLCHOLINE BRAIN LEVEL; ANESTHESIA MECHANISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENCY; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; HYPOGLYCEMIA; INHALATION ANESTHESIA; INHALATIONAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MINIMUM LUNG ALVEOLUS CONCENTRATION; NEUROPHYSIOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANESTHETICS, INHALATION; ANIMALS; BLOOD GLUCOSE; BRAIN; DRUG INTERACTIONS; ELECTROENCEPHALOGRAPHY; HALOTHANE; INSULIN; PARASYMPATHOMIMETICS; PHYSOSTIGMINE; PULMONARY ALVEOLI; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0030769054     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199708000-00023     Document Type: Article

References (28)

1. Siesjö BK: Hypoglycemia, brain metabolism, and brain damage. Diabetes Metab Rev 1988; 4:113-44
2. Auer RN, Siesjö BK: Hypoglycaemia: Brain neurochemistry and neuropathology. Baillière's clin Endocrinol Metabo 1993; 7:611-25
3. + channels. Science 1990; 247:852-4
4. Sieber FE, Traystman RJ: Special issues: Glucose and brain. Crit Care Med 1992; 20:104-14
5. Cryer PE: Glucose counterregulation: Prevention and correction of hypoglycemia in humans. Am J Physiol 1993; 264:E149-55
6. Welsh B, Wecker L: Effects of streptozotocin-induced diabetes on acetylcholine metabolism in rat brain. Neurochem Res 1991; 16:453-60
7. Dash NK, Azam M, Gupta G, Baquer NZ: Effect of hyperglycemia on acetylcholinesterase and catecholamine levels in rat brain and heart. Biochem Int 1991; 23:261-9
8. Brian JB, Bogan L, Kennedy RH, Seifen E: The impact of streptozotocin-induced diabetes on the minimum alveolar anesthetic concentration (MAC) of inhaled anesthetics in the rat. Anesth Analg 1993; 77:342-5
9. Ghajar JBG, Gibson GE, Duffy TE: Regional acetylcholine metabolism in brain during acute hypoglycemia and recovery. J Neurochem 1985; 44:94-8
10. Norberg K, Siesjö BK: Oxidative metabolism of the cerebral cortex of the rat in severe insulin-induced hypoglycaemia. J Neurochem 1976; 26:345-52
11. Romano JA, Shih TM: Cholinergic mechanisms of analgesia produced by physostigmine, morphine and cold water swimming. Neuropharmacology 1983; 22:827-33
12. Saelens JK, Simke JP, Allen MP, Conroy CA: Some of the dynamics of choline and acetylcholine metabolism in rat brain. Arch Int Pharmacodyn 1973; 203:305-12
13. Kato H, Aikawa H, Yamamoto M, Shigeta S, Shinohara Y: Effect of physostigmine on acetylcholine and monoamine metabolites in rat frontal cortex with lesions of the nucleus basalis of Meynert. Clin Neurol 1994; 34:224-8
14. White PF, Johnston RR, Eger EI II : Determination of anesthetic requirement in rats. ANESTHESIOLOGY 1974; 40:52-7
15. Eger EI II, Saidman LJ, Brandstater B: Minimum alveolar anesthetic concentration: a standard of anesthetic potency. ANESTHESIOLOGY 1965; 26:756-63
16. Akunne HC, Soliman KFA: The role of opioid receptors in diabetes and hyperglycemia-induced changes in pain threshold in the rat. Psychopharmacology 1987; 93:167-72
17. Lee JH, McCarty R: Glycemic control of pain threshold in diabetic and control rats. Physiol Behav 1990; 47:225-30
18. Thye-Rønn P, Sindrup SH, Arendt-Nielsen L, Brennum J, Hother-Nielsen O, Beck-Nielsen H: Effect of short-term hyperglycemia per se on nociceptive and non-nociceptive thresholds. Pain 1994; 56:43-9
19. Baskin DG: Insulin in the brain. Ann Rev Physiol 1987; 49:335-47
20. Moore RD: Effects of insulin upon ion transport. Biochem Biophys Acta 1983; 737:1-49
21. Dayton HE, Garrett RL: Production of analgesia by cholinergic drugs. Proc Soc Exp Biol Med 1973; 142:1011-3
22. Pleuvry BJ, Tobias MA: Comparison of the antinociceptive activities of physostigmine, oxotremorine and morphine in the mouse. Br J Pharmac 1971; 43:706-14
23. Hrbek J, Rypka M, Hrbek J Jr: Effects of single administration of scopolamine, physostigmine and their combination on biogenic amine levels in rat brain. Acta Univ Palacki Olomuce. Fac Med 1989; 121:271-5
24. Schultz JA, Hoffman WE, Albrecht RF: Sympathetic stimulation with physostigmine worsens outcome from incomplete brain ischemia in rats. ANESTHESIOLOGY 1993; 79:114-21
25. Pereira EFR, Reinhardt-Maelicke S, Schrattenholz A, Maelicke A, Albuquerque EX: Identification and functional characterization of a new agonist site on nicotinic acetylcholine receptors of cultured hippocampal neurons. J Pharmacol Exper Ther 1995; 265:1474-91
26. Storch A, Schrattenholz A, Cooper JC, Ghani EMA, Gutbrod O, Weber KH, Reinhardt S, Lobron C, Hermsen B, Soskic V, Pereira EFR, Albuquerque EX, Methfessel C, Maelicke A: Physostigmine, galanthamine and codeine act as 'noncompetitive nicotinic receptor agonists' on clonal rat pheochromocytoma cells. Eur J Pharmacol Mol Pharmacol Sec 1995; 290:207-19
27. Zucker J: Central cholinergic depression reduces MAC for isoflurane in rats. Anesth Analg 1991; 72:790-5
28. Horrigan RW: Physostigmine and anesthetic requirement for halothane in dogs. Anesth Analg 1978; 57:180-5